Entering the US market means compliance with the US Food and Drug Administration and international quality standards. While the products might be fine, the processes behind them may not be as robust as needed to comply, as a leading New Zealand medical device company, Medifab found.
Most cybersecurity is making up for weak platforms. We need to address the fundamentals, design platforms that prevent out-of-bounds access[…]
For most developers the security/performance trade off is still the hardest one to tackle, even as the cost of processing[…]
RISC has been overhyped. While it is an interesting low-level processor architecture, what the world needs is high-level system architectures,[…]
There are two flaws that are widespread in the industry here. The first is that any platform or language should[…]
Ajai Chowdhry, one of the founders and CEO of HCL is married to a cousin of a cousin of mine.[…]